Cadila Pharma awarded for innovative product for its Rabies Vaccine

Homegrown pharma major, Cadila Pharmaceuticals’ breakthrough three-dose rabies vaccine, Thrabis, has won the top honour at the The Golden Globe Tigers Awards, the company announced. The company received ‘Innovative Product of the Year’ Award for ThRabis at an event held in Malaysia.
Launched in April last year, ThRabis is the world’s first three-dose recombinant nanoparticle-based rabies G protein vaccine. While other rabies vaccines require five injections spread over 28 days to complete the full regimen, ThRabis has a simpler and more convenient three-dose regimen.
In a year, at least 1 lakh vials of ThRabis have been administered, thus helping at least 35,000 animal bite victims.
We are confident that ThRabis will prove to be a game-changer in the fight against rabies and help in eliminating rabies from the country by 2030 and world in the long run.
Source: Timesofindia